Skip to main content
. 2017 Apr 18;12(4):e0174241. doi: 10.1371/journal.pone.0174241

Fig 1. SLCAs inhibits growth of cancer cells.

Fig 1

Cancer cell lines as well as primary HUVEC cells were subjected to different concentrations of SLCA B, SLCA C, doxorubicin and Paclitaxel for 48 h. Graphical representation of percent growth inhibition GI50 for (a) SLCA B (b) SLCA C. The data represents mean ± SD of three independent experiments.